ATE218126T1 - Phenylpiperidin-derivate - Google Patents

Phenylpiperidin-derivate

Info

Publication number
ATE218126T1
ATE218126T1 AT96930358T AT96930358T ATE218126T1 AT E218126 T1 ATE218126 T1 AT E218126T1 AT 96930358 T AT96930358 T AT 96930358T AT 96930358 T AT96930358 T AT 96930358T AT E218126 T1 ATE218126 T1 AT E218126T1
Authority
AT
Austria
Prior art keywords
represents hydrogen
halogen
phenylpiperidine
lower alkyl
alkyl
Prior art date
Application number
AT96930358T
Other languages
English (en)
Inventor
Toshiaki Kumazawa
Hirokazu Koshimura
Shigeru Aono
Shunji Ichikawa
Shigeto Kitamura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE218126T1 publication Critical patent/ATE218126T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96930358T 1995-09-13 1996-09-11 Phenylpiperidin-derivate ATE218126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23502295 1995-09-13
PCT/JP1996/002589 WO1997010213A1 (en) 1995-09-13 1996-09-11 Phenylpiperidine derivatives

Publications (1)

Publication Number Publication Date
ATE218126T1 true ATE218126T1 (de) 2002-06-15

Family

ID=16979926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96930358T ATE218126T1 (de) 1995-09-13 1996-09-11 Phenylpiperidin-derivate

Country Status (7)

Country Link
US (1) US6150355A (de)
EP (1) EP0974583B1 (de)
AT (1) ATE218126T1 (de)
AU (1) AU6943996A (de)
CA (1) CA2231773A1 (de)
DE (1) DE69621469T2 (de)
WO (1) WO1997010213A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999037619A1 (en) 1998-01-21 1999-07-29 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DK1049700T3 (da) 1998-01-21 2006-02-20 Millennium Pharm Inc Kemokinreceptorantagonister og fremgangsmåder til anvendelse deraf
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
JP3989247B2 (ja) 1999-12-06 2007-10-10 ユーロ−セルティーク エス.エイ. ノシセプチン受容体親和性を有するトリアゾスピロ化合物
HK1049799A1 (zh) 1999-12-06 2003-05-30 Euro-Celtique, S.A. 具有类鸦片受体亲和力的三级氨基化合物
JP2003524634A (ja) 1999-12-06 2003-08-19 ユーロ−セルティーク,エス.エイ. ノシセプチン受容体親和性を有するベンズイミダゾール化合物
EP2033644A1 (de) 2001-04-18 2009-03-11 Euro-Celtique S.A. Spiroinden- und Spiroindan-Verbindungen
ATE410165T1 (de) 2001-04-18 2008-10-15 Euro Celtique Sa Nociceptin-analoga
CN1516584A (zh) 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物
RU2268883C2 (ru) 2001-04-18 2006-01-27 Эро-Селтик, С.А. Аналоги ноницептина и фармацевтическая композиция на их основе
ATE403431T1 (de) 2001-04-18 2008-08-15 Euro Celtique Sa Benzimidazolon-verbindungen
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) * 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
JP2009525269A (ja) 2006-01-30 2009-07-09 ユーロ−セルティーク エス.エイ. カルシウムチャネルブロッカーとしての環状尿素化合物
US8198305B2 (en) * 2007-04-13 2012-06-12 Concert Pharmaceuticals Inc. 1,2-benzisoxazol-3-yl compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225167A (ja) * 1985-03-28 1986-10-06 Yoshitomi Pharmaceut Ind Ltd ベンゾ〔g〕キノリン誘導体
JPH02250A (ja) * 1987-10-14 1990-01-05 Kyowa Hakko Kogyo Co Ltd 三環式化合物
US4882351A (en) * 1987-10-14 1989-11-21 Roussel Uclaf Tricyclic compounds
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors

Also Published As

Publication number Publication date
DE69621469T2 (de) 2002-12-12
EP0974583A1 (de) 2000-01-26
WO1997010213A1 (en) 1997-03-20
US6150355A (en) 2000-11-21
EP0974583B1 (de) 2002-05-29
EP0974583A4 (de) 2000-03-08
DE69621469D1 (de) 2002-07-04
AU6943996A (en) 1997-04-01
CA2231773A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
DE69621469D1 (de) Phenylpiperidin-derivate
ATE282630T1 (de) Dolastatin-derivate
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ATE107499T1 (de) Haarkräftigungsmittel.
AU9281198A (en) Benzofuran derivatives
DE69426602D1 (de) 2,3-diaminopropionsäurederivate
DK0695755T3 (da) Pyrrolocarbazoler
ATE183189T1 (de) Antifungale sordaridinderivate
ATE456564T1 (de) Octahydrobenzimidazolon-verbindungen als analgetika
ATE178056T1 (de) Substituierte tertiäre amine und deren salze
AU696948B2 (en) Piperidine derivatives
AU3784597A (en) Fat emulsion containing xanthine derivative
EP1031556A4 (de) 2-phenoxyanilin-derivate
EP1000923A4 (de) Cyclopentenonderivate
ATE90685T1 (de) Disaccharidderivate.
DK0627443T3 (da) 3,4-dideoxymycaminosyltylonolidderivat og fremstilling deraf
DE69300318D1 (de) Flavonderivate.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties